Central tsh dysregulation in a patient with familial non-autoimmune autosomal dominant hyperthyroidism due to a novel thyroid-stimulating hormone receptor disease-causing variant

3Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.

Abstract

Background and Objectives. Familial non-autoimmune autosomal dominant hyperthy-roidism (FNAH) is a rare cause of childhood hyperthyroidism. It is caused by the thy-roid-stimulating hormone receptor (TSHR) gene variants. So far, only around 40 families with FNAH have been reported. Patients with activating TSHR variants demonstrated the same classical signs and symptoms of hyperthyroidism as seen in patients with Graves’ disease. Since 2012, abla-tive therapy is recommended to avoid relapses of hyperthyroidism and its consequences. Case Presentation. We presented a young adult male patient with a novel heterozygous TSHR dis-ease-causing variant p.Arg418Lys (c.1253G>A) in the exon 10, who presented with a mild but progressive FNAH, with a follow-up since infancy. Discussion. Constantly suppressed TSH, in-cluding during the euthyreosis in childhood and hypothyreosis after iodine ablation therapy, suggested central dysregulation of the TSH secretion.

Cite

CITATION STYLE

APA

Omladic, J. S., Pajek, M., Groselj, U., Podkrajsek, K. T., Stefanija, M. A., Tansek, M. Z., … Schweiger, D. S. (2021). Central tsh dysregulation in a patient with familial non-autoimmune autosomal dominant hyperthyroidism due to a novel thyroid-stimulating hormone receptor disease-causing variant. Medicina (Lithuania), 57(3), 1–9. https://doi.org/10.3390/medicina57030196

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free